Conditions

Dr. Tamara Hannon explains how her type 2 patients make the transition to adult-care physicians. Because type 2 is far more common in adults, endocrinologists and physicians who treat adults are actually more used to treating the disease than pediatricians who rarely see type 2 patients. 

Dr. Tamara Hannon addresses Steve’s questions on the future of type 2 diabetes in children, noting that unless we can begin to make changes as a society, the rates will just keep increasing as the obesity rates just keep going up.

Recent scientific evidence and better tools to monitor for hypoglycemia helped establish the new position statement…. Anne Peters, MD, FACP, professor at the Keck School of Medicine, University of Southern California, said during a press conference at the American Diabetes Association’s 74th Scientific Sessions, “Our goal here is to present …

Depression has been linked with worse survival in a 20-year observational study of patients with type 1 diabetes…. 

Findings suggest clinicians can prevent or delay the onset of type 2 diabetes "over a very long period of time"….

Treatment of prediabetes and prevention of type 2 diabetes reduces cardiovascular risk…. 

Richard S. Beaser, MD Medications that Increase Insulin Secretion: SULFONYLUREAS CLASS SUMMARY: Action: Insulin secretagogues. Initial effects are to increase insulin secretory capacity. With establishment of long-term glucose control, this increase may not persist and other extrapancreatic effects, either direct or indirect, may also occur. Required for efficacy: Some remaining …

Among diabetes patients receiving metformin, the addition of insulin compared with a sulfonylurea was associated with an increased risk of nonfatal cardiovascular outcomes and all-cause death…. 

With already increased risk of weight gain in adolescents with type 1 diabetes, certain traits in these children can also be markers for even higher weight gain…. 

Available studies to date looking at the benefits of using SGLT-2 inhibitors have shown positive results…. The discovery of sodium-glucose co-transporter 2 (SGLT2) inhibitors, with a novel mechanism independent of insulin secretion or sensitization, offered a new therapeutic approach for the management of type 2 diabetes mellitus. The aim of this …